Caps Pharma Profile
Key Indicators
- Authorised Capital ₹ 0.10 M
as on 16-11-2024
- Paid Up Capital ₹ 0.10 M
as on 16-11-2024
- Company Age 13 Year, 18 Days
- Last Filing with ROC 31 Mar 2024
- Revenue 77.52%
(FY 2023)
- Profit 1781.54%
(FY 2023)
- Ebitda 396.74%
(FY 2023)
- Net Worth 42.25%
(FY 2023)
- Total Assets 14.78%
(FY 2023)
About Caps Pharma
The Corporate was formerly known as Caps Pharma Private Limited. The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 0.10 M and a paid-up capital of Rs 0.10 M, as per Ministry of Corporate Affairs (MCA) records.
Chander Dhall, Poonam Dhall, Abhinav Kumar, and One other member serve as directors at the Company.
- CIN/LLPIN
U51909DL2011PTC228386
- Company No.
228386
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
07 Dec 2011
- Date of AGM
30 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Delhi
Industry
Company Details
- Location
New Delhi, India
- Telephone
- Email Address
- Website
-
- Social Media-
What products or services does Caps Pharma Private Limited offer?
Caps Pharma Private Limited offers a wide range of products and services, including Nutraceuticals & Dietary Supplements, Dietary Supplements, Protein Powder.
Who are the key members and board of directors at Caps Pharma?
Board Members(4)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Chander Dhall  | Director | 09-May-2017 | Current |
| Poonam Dhall | Director | 01-Dec-2017 | Current |
| Abhinav Kumar | Director | 07-Dec-2011 | Current |
| Siddhanta Kumar | Director | 20-Jul-2020 | Current |
Financial Performance of Caps Pharma.
Caps Pharma Private Limited, for the financial year ended 2023, experienced significant growth in revenue, with a 77.52% increase. The company also saw a substantial improvement in profitability, with a 1781.54% increase in profit. The company's net worth Soared by an impressive increase of 42.25%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Caps Pharma?
In 2023, Caps Pharma had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
_LIMITED.webp)
Cee Pee Creations Private LimitedActive 20 years 6 monthsChander Dhall, Poonam Dhall and 1 more are mutual person
- Caps Tradelink Private LimitedActive 14 years 9 months
Chander Dhall, Poonam Dhall and 2 more are mutual person
- B B Creations Private LimitedActive 16 years 10 months
Chander Dhall and Poonam Dhall are mutual person
- Caps Lifesciences Private LimitedActive 11 years 9 months
Abhinav Kumar and Siddhanta Kumar are mutual person
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Caps Pharma?
Unlock and access historical data on people associated with Caps Pharma, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Caps Pharma, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Caps Pharma's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
